Rossari Biotech Ltd
ROSSARI NSE
Rossari Biotech Ltd
CommoditiesNSE: ROSSARI BSE: 543213 Specialty Chemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹2,247 Cr
Volatility
Moderate
P/E Ratio
16.2
Book Value
₹225.97
52W High
₹1,574.95
52W Low
₹1,277.2
Technical Indicators
Key Insights
Weaknesses
2- Company has a low return on equity of 12.6% over last 3 years.
- Dividend payout has been low at 2.24% of profits over last 3 years
Growth Rate
Revenue Growth
6.91% ↘
Net Income Growth
1.00% →
Cash Flow Change
-
ROE
12.00% ↗
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | 16 | 16 | 14 | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 |
| EPS in Rs | 4.66 | 5.25 | 5.3 | 5.97 | 6.23 | 6.18 | 6.32 | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 |
| Expenses | 335 | 352 | 353 | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 |
| Interest | 5 | 4 | 6 | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 |
| Net Profit | 26 | 29 | 29 | 33 | 34 | 34 | 35 | 35 | 32 | 34 | 34 | 37 | 33 |
| OPM % | 14% | 13% | 14% | 13% | 14% | 13% | 13% | 13% | 13% | 12% | 12% | 12% | 12% |
| Operating Profit | 54 | 55 | 58 | 64 | 64 | 64 | 65 | 66 | 65 | 69 | 68 | 72 | 69 |
| Other Income | 1 | 3 | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 |
| PBT | 35 | 37 | 39 | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 |
| Sales | 389 | 406 | 411 | 483 | 464 | 473 | 490 | 498 | 513 | 580 | 544 | 586 | 582 |
| Tax % | 26% | 22% | 26% | 26% | 28% | 25% | 26% | 27% | 25% | 28% | 27% | 26% | 23% |
Profit & Loss
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 74 |
| Div. Payout % | 0% | 4% | 3% | 3% | 3% | 2% | 2% | — |
| EPS in Rs | 104 | 12.86 | 15.45 | 17.74 | 19.45 | 23.66 | 24.63 | 24.87 |
| Expenses | 438 | 495 | 586 | 1,299 | 1,433 | 1,581 | 1,815 | 2,013 |
| Interest | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 25 |
| Net Profit | 46 | 65 | 80 | 98 | 107 | 131 | 136 | 138 |
| OPM % | 15% | 17% | 17% | 12% | 13% | 14% | 13% | 12% |
| Operating Profit | 78 | 105 | 124 | 184 | 223 | 250 | 265 | 278 |
| Other Income | 1 | 4 | 9 | 13 | 6 | 8 | 5 | 7 |
| PBT | 63 | 88 | 107 | 136 | 144 | 178 | 185 | 186 |
| Sales | 516 | 600 | 709 | 1,483 | 1,656 | 1,831 | 2,080 | 2,291 |
| Tax % | 28% | 26% | 25% | 28% | 26% | 26% | 26% | — |
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Borrowings | 8 | 67 | 0 | 8 | 74 | 119 | 218 | 353 |
| CWIP | 3 | 22 | 0 | 1 | 16 | 47 | 140 | 247 |
| Equity Capital | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| Fixed Assets | 74 | 94 | 181 | 607 | 585 | 578 | 598 | 630 |
| Investments | 0 | 18 | 0 | 36 | 51 | 63 | 84 | 20 |
| Other Assets | 173 | 338 | 379 | 611 | 712 | 880 | 1,063 | 1,190 |
| Other Liabilities | 118 | 118 | 152 | 442 | 375 | 401 | 482 | 484 |
| Reserves | 119 | 277 | 398 | 794 | 904 | 1,037 | 1,174 | 1,240 |
| Total Assets | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,088 |
| Total Liabilities | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,088 |
Cash Flow
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| CFO/OP | 118 | 74 | 64 | 43 | 89 | 39 | 74 |
| Financing | -29 | 157 | -25 | 292 | 61 | 16 | 65 |
| Investing | -37 | -190 | -37 | -299 | -181 | -103 | -183 |
| Operating | 71 | 57 | 48 | 29 | 152 | 43 | 137 |
| Free Cash Flow | 27 | -19 | -8 | -7 | 120 | -83 | -21 |
| Net Cash Flow | 5 | 23 | -14 | 22 | 32 | -44 | 19 |
Ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Cash Conversion Cycle | 6 | 19 | 46 | 76 | 80 | 103 | 101 |
| Days Payable | 114 | 95 | 104 | 61 | 56 | 62 | 73 |
| Debtor Days | 61 | 57 | 74 | 75 | 78 | 85 | 83 |
| Inventory Days | 59 | 57 | 75 | 63 | 59 | 80 | 90 |
| ROCE % | — | 38% | 29% | 24% | 18% | 18% | 16% |
| Working Capital Days | 23 | 22 | 60 | 62 | 49 | 70 | 69 |
Documents
Financial Year 2025
from bse
from bse
Financial Year 2021
from bse
from bse
Financial Year 2022
from bse
from bse
Financial Year 2023
from bse
from bse
Financial Year 2024
from bse
from bse
Concall - Oct 2025
Oct 2025
Concall - Oct 2024
Oct 2024
Concall - Oct 2024
Oct 2024
Concall - Oct 2023
Oct 2023
Concall - Oct 2021
Oct 2021
Concall - Oct 2020
Oct 2020
Concall - Nov 2022
Nov 2022
Concall - May 2025
May 2025
Concall - May 2024
May 2024
Concall - May 2023
May 2023
Concall - May 2022
May 2022
Concall - May 2022
May 2022
Concall - May 2021
May 2021
Concall - Jun 2021
Jun 2021
Concall - Jul 2025
Jul 2025
Concall - Jul 2024
Jul 2024
Concall - Jul 2021
Jul 2021
Concall - Jan 2026
Jan 2026
Concall - Jan 2025
Jan 2025
Concall - Jan 2024
Jan 2024
Concall - Feb 2023
Feb 2023
Concall - Feb 2023
Feb 2023
Concall - Feb 2022
Feb 2022
Concall - Feb 2021
Feb 2021
Concall - Aug 2023
Aug 2023
Concall - Aug 2022
Aug 2022
Concall - Aug 2021
Aug 2021
Concall - Aug 2020
Aug 2020
Rating update
9 Sep 2022 from icra
9 Sep 2022 from icra
Rating update
4 Dec 2025 from icra
4 Dec 2025 from icra
Rating update
26 Jul 2021 from icra
26 Jul 2021 from icra
Rating update
24 Oct 2024 from icra
24 Oct 2024 from icra
Rating update
14 Jul 2021 from icra
14 Jul 2021 from icra
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
8h - Unitop commissioned remaining 15,000 MTPA ethoxylation capacity; total 66,000 MTPA effective March 31, 2026.
8h - Unitop commissioned remaining 15,000 MTPA ethoxylation capacity; total 66,000 MTPA effective March 31, 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7h - Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
7h - Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
Announcement Under Regulation 30 Of SEBI (LODR), Regulation 2015.
6h - Unitop Chemicals to sell Saki Naka office premises for about Rs. 10 crore by Q2 FY27.
6h - Unitop Chemicals to sell Saki Naka office premises for about Rs. 10 crore by Q2 FY27.
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
6h - Rossari Global DMCC renamed Rossari Global FZCO effective March 23, 2026.
6h - Rossari Global DMCC renamed Rossari Global FZCO effective March 23, 2026.
Announcement Under Regulation 30 Of SEBI (LODR), 2015
29 Jan - Arbitral award dated Jan 21, 2026: pay INR 97,90,617 plus 12% interest; put option claim dismissed.
29 Jan - Arbitral award dated Jan 21, 2026: pay INR 97,90,617 plus 12% interest; put option claim dismissed.
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
24 Mar - Rossari Global DMCC renamed Rossari Global FZCO effective March 23, 2026.
24 Mar - Rossari Global DMCC renamed Rossari Global FZCO effective March 23, 2026.
Announcement Under Regulation 30 Of SEBI (LODR), 2015
23 Jan - Sale of Rossari Biotech's Kanjurmarg office premises completed January 23, 2026; details previously disclosed January 17, 2026.
23 Jan - Sale of Rossari Biotech's Kanjurmarg office premises completed January 23, 2026; details previously disclosed January 17, 2026.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
23 Jan - Of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19, 2026.
23 Jan - Of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19, 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 Feb - Investor/analyst meet at MANTHAN Systematix conference on Feb 9, 2026, 02:00 PM IST, Mumbai.
2 Feb - Investor/analyst meet at MANTHAN Systematix conference on Feb 9, 2026, 02:00 PM IST, Mumbai.
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
18 Feb - Infused SAR 8 million (8,000 shares at SAR1,000) into wholly-owned Rossari International on Feb 18, 2026.
18 Feb - Infused SAR 8 million (8,000 shares at SAR1,000) into wholly-owned Rossari International on Feb 18, 2026.
Frequently Asked Questions about Rossari Biotech Ltd
What does Rossari Biotech Ltd do?
Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]
Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition
The company has two R&D f...
Where is Rossari Biotech Ltd (ROSSARI) listed?
Rossari Biotech Ltd is listed on the Indian stock exchanges. It is listed on NSE: ROSSARI and BSE: 543213. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Rossari Biotech Ltd belong to?
Rossari Biotech Ltd operates in the Commodities sector within the Specialty Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Rossari Biotech Ltd?
Rossari Biotech Ltd has a market capitalisation of approximately ₹2247.46 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Rossari Biotech Ltd?
The Price-to-Earnings (PE) ratio of Rossari Biotech Ltd is 16.20. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Rossari Biotech Ltd?
Over the past 52 weeks, Rossari Biotech Ltd has traded between a low of ₹1,277.2 and a high of ₹1,574.95. This range helps investors understand the stock's price volatility and recent trading levels.
Does Rossari Biotech Ltd pay dividends?
Yes, Rossari Biotech Ltd has a dividend yield of 0.12%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
How can I research Rossari Biotech Ltd on Tapetide?
On Tapetide, you can view Rossari Biotech Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1] Their 3 main product categories are [2]: - Home, personal care, and performance chemicals - Textile specialty chemical - Animal health and nutrition The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]